KRAS and neoplasm: However, even in the absence of tumor acquired KRAS mutations, patients with the KRAS-variant have a “KRAS-addicted” gene expression signature in their respective tumors (12), perhaps due to disruption of KRAS regulation by the miRNA let-7.